| JAGSNPHARM | | | 639.65 23.25 3.77% |
Jagsonpal Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Jagsonpal Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jagsonpal Pharmaceuticals is a good investment. Please check the relationship between Jagsonpal Pharmaceuticals Ebitda and its Cost Of Revenue accounts. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jagsonpal Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
Ebitda vs Cost Of Revenue
Ebitda vs Cost Of Revenue Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of
Jagsonpal Pharmaceuticals Ebitda account and
Cost Of Revenue. At this time, the significance of the direction appears to have strong relationship.
The correlation between Jagsonpal Pharmaceuticals' Ebitda and Cost Of Revenue is 0.65. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Cost Of Revenue in the same time period over historical financial statements of Jagsonpal Pharmaceuticals Limited, assuming nothing else is changed. The correlation between historical values of Jagsonpal Pharmaceuticals' Ebitda and Cost Of Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Jagsonpal Pharmaceuticals Limited are associated (or correlated) with its Cost Of Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Cost Of Revenue has no effect on the direction of Ebitda i.e., Jagsonpal Pharmaceuticals' Ebitda and Cost Of Revenue go up and down completely randomly.
Correlation Coefficient | 0.65 |
| Relationship Direction | Positive |
| Relationship Strength | Significant |
Ebitda
Cost Of Revenue
Cost of Revenue is found on Jagsonpal Pharmaceuticals income statement and represents the costs associated with goods and services Jagsonpal Pharmaceuticals provides. Indirect cost, such as salaries, is not included. In other words, cost of revenue is the total cost incurred to obtain a sale. It is more than the traditional cost of goods sold, since it includes specific selling and marketing activities.
Most indicators from Jagsonpal Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jagsonpal Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out
Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jagsonpal Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in board of governors.
The Jagsonpal Pharmaceuticals' current
Selling General Administrative is estimated to increase to about 72.9
M, while
Tax Provision is projected to decrease to under 38.7
M.
Jagsonpal Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Jagsonpal Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Jagsonpal Pharmaceuticals fundamental ratios Accounts
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
Other Information on Investing in Jagsonpal Stock
Balance Sheet is a snapshot of the
financial position of Jagsonpal Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Jagsonpal Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Jagsonpal Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Jagsonpal currently owns. An asset can also be divided into two categories, current and non-current.